Current Kidney Transplant Clinical Trials
For more information about clinical trials at
the Penn Transplant Institute, read our answers
to frequently
asked questions.
Studies
Open for Enrollment |
Clinical, immunologic, pharmacologic consequences of kidney transplantation in people with HIV infection
Sponsor: NIH
Principal Investigator: Kim Olthoff, MD |
Penn Human Islet Production Lab
Sponsor: NIH
|
Islet cell transplantation in patients with Type I Diabetes
Sponsor: Juvenile Diabetes Foundation
Principal Investigator: Ali Naji, MD, PhD |
A randomized, prospective single-center study comparing a rapid discontinuation of corticosteroids (steroid withdrawal) with corticosteroid therapy in kidney transplantation using Mycophenolate Mofetil and Tacrolimus maintenance therapy
Principal Investigator: Simin Goral, MD |
Renal Transplant Cohort Study
Sponsor: American Heart Association
Principal Investigator: Sylvia Rosas, MD |
Clinical Trials in Organ Transplantation (CTOT)
Sponsor: NIH
Principal Investigator: Abraham Shaked, MD, PhD |
A Phase IV, Randomized, Open-Label, Comparative, Single-Center Study to Assess Gastrointestinal Adverse Event Outcomes of De Novo African American Kidney Transplant Recipients treated with Prograf (tacrolimus) /CellCept (mycophenolate mofetil)/Corticosteroids versus Prograf (tacrolimus)/Myfortic (enteric coated mycophenolate sodium)/Corticosteroids
Principal Investigator: Roy Bloom, MD |
|